Who Paid My Doc
Nalu Neurostimulation System
Device Pain Management
General payments
$3,839,363
Research payments
$10,518,202
Through program year 2025, $3,839,363 in general payments and $10,518,202 in research payments were reported against Nalu Neurostimulation System (Pain Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $884,190 | 5,500 |
| 2025 | Research | $1,059,055 | 193 |
| 2024 | General | $822,964 | 9,707 |
| 2024 | Research | $4,884,895 | 404 |
| 2023 | General | $759,089 | 5,823 |
| 2023 | Research | $2,771,142 | 305 |
| 2022 | General | $776,492 | 5,269 |
| 2022 | Research | $1,258,947 | 147 |
| 2021 | General | $379,700 | 4,597 |
| 2021 | Research | $495,482 | 62 |
| 2020 | General | $216,928 | 480 |
| 2020 | Research | $48,682 | 8 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 87 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
31,376 general · 1,119 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.